Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
None
JAKPOT (JAK Inhibitors and Predictors of Outcome in rheumaToid Arthritis)

Rheumatoid arthritis (RA) is a chronic, progressive autoimmune disease associated with inflammation and destruction of joints and systemic effects, which result in significant impact on patient's quality of life and function. Sustained remission or low disease activity is the target to achieve in RA management. Ultrasound (US) is an imaging …

abatacept
synovitis
tumor necrosis factor
baricitinib
DMARD
  • 5 views
  • 16 Jul, 2021
  • 1 location
None
Cardiovascular Risk and Chronic Inflammatory Rheumatism

Chronic inflammatory rheumatism and inflammation can increase the risk of cardiovascular problems. Indeed, these diseases can increase the risk of myocardial infarction. The objective of this project is a better understanding and preventing the risk of cardiovascular problems in chronic inflammatory rheumatism through the study on the long-term flexibility of …

abatacept
NSAID
DMARD
ankylosing spondylitis
infarct
  • 6 views
  • 21 Jan, 2021
None
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

This is a phase III, multicenter, randomized, open label, clinical trial to test that hypothesis that plasmapheresis plus rituximab prior to kidney transplantation can prevent recurrent FSGS in children and adults.

investigational drug
minimal change disease
kidney transplant
hepatitis c
proteinuria
  • 83 views
  • 01 Dec, 2021
  • 14 locations
None
Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.

One-center observational study aimed at determining the survival of patients with rheumatoid arthritis treated with targeted synthetic disease-modifying drugs (FAMEsd) and biologic disease-modifying drugs (FAMEb). These patients will be administered a series of medications and a follow-up will be carried out to analyze their evolution.

  • 0 views
  • 24 Nov, 2021
  • 1 location
None
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

The objective of this study is to identify a panel of immunological molecular and cellular biomarkers able to predict the success of major dose-reduction or discontinuation of abatacept in

abatacept
synovitis
methotrexate
corticosteroids
remission
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies

therapy for patients, discover disease related new pathways and biomarkers that can be helpful during diagnosis and monitoring abatacept targeted therapy responses.

  • 0 views
  • 25 Jan, 2021
  • 1 location